USP28 and neoplasm: Moreover, there is a significant correlation between USP28 and immune modulatory factors, clinical staging, checkpoint inhibitor responses, MSI (microsatellite instability), TMB (tumor mutational burden), CNV (copy number variation), MMR (mismatch repair) defects, and DNA methylation127.